RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer <i>in vitro</i> by modulating cathepsin B and MMP9 expression

Abstract

The results indicate that TRPV6 may promote prostate cancer progression in association with MMP9 and cathepsin B, thereby validating further research into TRPV6 as a useful therapeutic target for local invasion or metastasis of advanced prostate cancer.